oxprenolol has been researched along with Raynaud Disease in 3 studies
Oxprenolol: A beta-adrenergic antagonist used in the treatment of hypertension, angina pectoris, arrhythmias, and anxiety.
Raynaud Disease: An idiopathic vascular disorder characterized by bilateral Raynaud phenomenon, the abrupt onset of digital paleness or CYANOSIS in response to cold exposure or stress.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marshall, AJ | 1 |
| Roberts, CJ | 2 |
| Barritt, DW | 2 |
| Marshall, A | 1 |
| Sturm, A | 1 |
3 other studies available for oxprenolol and Raynaud Disease
| Article | Year |
|---|---|
Raynaud's phenomenon as side effect of beta-blockers in hypertension.
Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Female; Humans; Hypertension; Male; Methyldopa; Middle | 1976 |
Letter: Raynaud's phenomenon as side effect of beta-blockers.
Topics: Adrenergic beta-Antagonists; Atenolol; Humans; Oxprenolol; Propranolol; Raynaud Disease | 1976 |
[Letter: Peripheral blood circulation disorders due to beta receptor blockers?].
Topics: Adrenergic beta-Antagonists; Arterial Occlusive Diseases; Humans; Oxprenolol; Propranolol; Raynaud D | 1974 |